Find out more about our accelerator programmes, the application process and how you can get involved below
There will be four cohorts across three years, cohorts are expected to begin every 8 months. Find out more here.
Making multiple applications will not negatively impact the assessment of your application.
We always welcome new partnerships and collaborators. Please email us at email@example.com for a more detailed discussion.
All of our accelerator programmes are a full time offering a salary replacement for early career researchers released onto the programme. The Venture Accelerator is an eight programme and the Challenge Accelerator is a six month programme.
PhD students are eligible subject to the following conditions – your supervisor would be happy for you to interrupt your PhD, interrupting your PhD will not negatively impact on your PhD, your PhD is not funded in a way that would be jeopardised if you were to interrupt your PhD.
The principal investigator will not necessarily be the existing PhD supervisor.
MedTech SuperConnector does not take IP. The IP ownership will reside within the respective HEI(s) associated with the participant(s).
The main purpose of the funding is to enable teams to work on their projects directly. Any external advice or consultancy should be kept to a minimum.
We are no longer accepting applications for our next cohort. Please check back in early 2021 for more information on the next intake.
If you have any questions about the programme please email us at firstname.lastname@example.org.
We are no longer accepting applications for Cohort Four Challenge Accelerator Programme.
If you have applied for Cohort Four Challenge Accelerator Programme we will be in touch with you directly about any next steps in the application process.
There is a possibility that we can arrange for an alternative date, but we cannot guarantee that there will still be places available on the cohort following the scheduled interview dates.
The upfront entrepreneurial training and onboarding bootcamp is an essential part of the programme. Exemption will only be given under extenuating circumstances.
We are offering a salary replacement for early career researchers released onto the programme. Final replacement amounts will be decided at offer stage.
Remaining agile and responsive to the changing circumstances is our number one priority and we aim to continue to deliver all aspects of the programme to the same high standard. We are monitoring the situation closely and will be carrying out all recruitment activity digitally along with the learning the portion of the programme for the foreseeable future.
Become a member
Join our mailing list to receive updates about Medtech SuperConnector.